Variation in Adherence Measures to Imatinib Therapy

PURPOSE: The introduction of tyrosine kinase inhibitors has transformed the care of patients with chronic myeloid leukemia, with survival approaching that of healthy individuals. Current-day challenges in chronic myeloid leukemia care include adherence to tyrosine kinase inhibitor therapy. We studie...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Glob Oncol
Asıl Yazarlar: Yanamandra, Uday, Malhotra, Pankaj, Sahu, K.K., Sushma, Yanamandra, Saini, Neha, Chauhan, Pooja, Gill, Jasmeen, Rikhi, Deepika, Khadwal, Alka, Prakash, Gaurav, Lad, Deepesh, Suri, Vikas, Kumari, Savita, Varma, Neelam, Varma, Subhash
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2017
Konular:
ORIGINAL REPORTS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6223484/
https://ncbi.nlm.nih.gov/pubmed/30241224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.2016.007906
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller